Rhodes Jennifer J sold ACAD
March 25, 2026 · Form 4 insider transaction
Rhodes Jennifer J sold 3,844 shares of Acadia Pharmaceuticals Inc. at $21.47 per share, a transaction worth $82.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,844
Price
$21.47
Total value
$82.5K
InsiderRhodes Jennifer J
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 25, 2026
Filing dateMarch 26, 2026
Shares owned after11,280
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).